Skip to content
Company Analysis

Haoxi Health Technology Limited HAO

A comprehensive view of key metrics, scores, and financial health for Haoxi Health Technology Limited

Overview of Haoxi Health Technology Limited

HAO NCM
Communication Services Advertising Agencies Micro Cap
Haoxi Health Technology Limited (HAO), is a Micro Cap company, in the Advertising Agencies industry, last closed at $1.18, about 20.3% undervalued vs fair value, -28.9% 1Y return, ranked 139/261 in sector.
$1.18
0.00%
As of March 13, 2026
Previous close • Vol 90d: 82.9%
52-Week Range
Market Cap
$70.14M
Enterprise Value
$63.52M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Haoxi Health Technology Limited.

Top Beats

Quick Facts

Website https://www.haoximedia.com
HQ Chaoyang
Employees 26
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$1
$1
$2
Current: $1.18 +20% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$32.8M
-32.4%%
Gross Profit
$927.8K
-66.3%%
Operating Income
$-2.0M
-216.5%%
Net Income
$3.9M
200.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Operating Cash Flow Margin
-10.2%
Poor

OCF / Revenue - cash profitability from operations

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
Analysis based on partial data. Some metrics unavailable for complete assessment.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Haoxi Health Technology Limited's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
44
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
38
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing HAO's balance between Growth (29.1%), Profitability (36.8%), and Safety (34.1%). Growth 29% Safety 34% Profitability 37%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

46th percentile vs peers
47
Key Signals
Revenue CAGR 3Y 5.1% 57p EPS Growth YoY 90.4% 66p EPS CAGR 3Y 60.0% 69p Rev Growth YoY -32.4% 13p
Strengths
  • Interest Coverage Ratio in top 20% of peers (91.25, 86th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Roic in top 20% of peers (10.3%, 84th percentile)
  • Net Profit Margin in top 20% of peers (11.8%, 81th percentile)
  • Current Ratio in top 20% of peers (5.05, 89th percentile)
Risks
  • Rev Growth Yoy in bottom 20% of peers (-32.4%)

Profitability

59th percentile vs peers
59
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

54th percentile vs peers
55
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Haoxi Health Technology Limited.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$1.42
- - -
+20.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info